Corticosteroid therapy for the pregnant asthmatic patient.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMID 1173879)

Published in JAMA on August 18, 1975

Authors

M Schatz, R Patterson, S Zeitz, J O'Rourke, H Melam

Articles by these authors

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell (2001) 19.75

A new generation of the IMAGIC image processing system. J Struct Biol (1996) 12.57

A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72

Single-particle electron cryo-microscopy: towards atomic resolution. Q Rev Biophys (2000) 4.86

Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med (1977) 4.14

Allergic reactions to insulin. JAMA (1971) 3.11

A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG (2011) 3.00

Isolation of a spiral-shaped bacterium from the cat stomach. Infect Immun (1988) 2.98

Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes (2001) 2.64

An uncultured gastric spiral organism is a newly identified Helicobacter in humans. J Infect Dis (1993) 2.53

Munchausen's stridor: non-organic laryngeal obstruction. Clin Allergy (1974) 2.19

D'oh! An analysis of the medical care provided to the family of Homer J. Simpson. CMAJ (1998) 2.04

Stevens-Johnson syndrome: getting ready for the year 2000 and beyond. Ann Allergy Asthma Immunol (1999) 2.01

Identification of the small subunit of ribulose 1,5-bisphosphate carboxylase as a product of wheat leaf cytoplasmic ribosomes. Arch Biochem Biophys (1976) 1.95

Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut (1996) 1.82

Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J Allergy Clin Immunol (1991) 1.73

Trimellitic anhydride-induced airway syndromes: clinical and immunologic studies. J Allergy Clin Immunol (1977) 1.71

National Ignition Facility laser performance status. Appl Opt (2007) 1.70

Serum immunoglobulin levels in pulmonary allergic aspergillosis and certain other lung diseases, with special reference to immunoglobulin E. Am J Med (1973) 1.69

Reducing delusional speech in chronic, paranoid schizophrenics. J Appl Behav Anal (1973) 1.68

Respiratory mast cells and basophiloid cells. I. Evidence that they are secreted into the bronchial lumen, morphology, degranulation and histamine release. Clin Exp Immunol (1974) 1.65

Cough variant asthma: usefulness of a diagnostic-therapeutic trial with prednisone. Ann Allergy (1992) 1.64

Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release. J Immunol (1983) 1.63

Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis (1978) 1.62

Strength testing with a portable dynamometer: reliability for upper and lower extremities. Arch Phys Med Rehabil (1987) 1.62

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol (1985) 1.58

The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis (1979) 1.57

The 70S Escherichia coli ribosome at 23 A resolution: fitting the ribosomal RNA. Structure (1995) 1.54

A time domain description for the pitch strength of iterated rippled noise. J Acoust Soc Am (1996) 1.50

Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann Neurol (1997) 1.49

Current concepts. Management of asthma during pregnancy. N Engl J Med (1985) 1.47

Effect of combined maternal and infant food-allergen avoidance on development of atopy in early infancy: a randomized study. J Allergy Clin Immunol (1989) 1.46

Molecular analysis of urease genes from a newly identified uncultured species of Helicobacter. Infect Immun (1994) 1.44

Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. J Allergy Clin Immunol (1993) 1.44

Herpes simplex virus associated with recurrent Stevens-Johnson syndrome. A management strategy. Arch Intern Med (1992) 1.43

Structure of the skeletal muscle calcium release channel activated with Ca2+ and AMP-PCP. Biophys J (1999) 1.43

Two contrasting cases of anaphylaxis seen simultaneously. Ann Allergy Asthma Immunol (2000) 1.41

Potentially fatal asthma and asthma deaths: knowledge is greater but implementation appears problematic. Ann Allergy Asthma Immunol (2000) 1.41

Idiopathic anaphylaxis. A clinical summary of 175 patients. Arch Intern Med (1990) 1.41

Anaphylactic reactivity to streptokinase. JAMA (1984) 1.41

Potentially fatal asthma. Ann Allergy (1990) 1.39

Idiopathic anaphylaxis: classification, evaluation, and treatment of 123 patients. J Allergy Clin Immunol (1988) 1.38

Electrocardiographic changes during human anaphylaxis. JAMA (1970) 1.36

Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol Appl Pharmacol (2001) 1.35

Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States. J Allergy Clin Immunol (1992) 1.34

Identification of patients at risk for anaphylaxis due to streptokinase. Arch Intern Med (1986) 1.34

Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol (1988) 1.34

Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci (1986) 1.33

Administration of local anesthetics to patients with a history of prior adverse reaction. J Allergy Clin Immunol (1978) 1.33

Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol (1982) 1.32

Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl Lewis X, and H. pylori UA915 expressing Lewis B classification of H. pylori lipopolysaccharides into glycotype families. Eur J Biochem (2000) 1.31

Systemic allergic reactions to ingested antigens. J Allergy (1969) 1.30

Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med (1986) 1.28

Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med (1982) 1.28

Animal models of the asthmatic state. Annu Rev Med (1974) 1.27

Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Leukemia (2006) 1.27

Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema. JAMA (1990) 1.26

Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol (1989) 1.26

Long term infection of the gastric mucosa with Helicobacter species does induce atrophic gastritis in an animal model of Helicobacter pylori infection. Zentralbl Bakteriol (1993) 1.24

In vitro production of IgE by lymphocytes from a patient with hyperimmunoglobulinaemia E, eosinophilia and increased lymphocytes carrying surface IgE. Clin Exp Immunol (1975) 1.23

Comparisons of reaginic antibodies from three species. J Immunol (1969) 1.23

Immediate-type hypersensitivity in dogs: cutaneous, anaphylactic, and respiratory responses to ascaris. J Lab Clin Med (1970) 1.21

The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol (1991) 1.21

Living histamine-containing cells from the bronchial lumens of humans. Description and comparison of histamine content with cells of rhesus monkeys. J Clin Invest (1977) 1.20

Sauna-takers disease. Hypersensitivity pneumonitis due to contaminated water in a home sauna. JAMA (1976) 1.20

Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J Immunol (1997) 1.20

Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex-mediated damage. J Allergy Clin Immunol (1985) 1.19

The safety of immunotherapy during pregnancy. J Allergy Clin Immunol (1978) 1.18

The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis. Infect Immun (1997) 1.16

Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol (2001) 1.16

Safety of therapy for allergic symptoms during pregnancy. Ann Intern Med (1978) 1.16

The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG (2013) 1.14

Immunotherapy for atopic disease. Adv Intern Med (1974) 1.14

Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol (1972) 1.13

Immunopatholgenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol (1977) 1.13

Application of enzyme-linked immunosorbent assay (ELISA) in diagnosis of allergic bronchopulmonary aspergillosis. J Lab Clin Med (1982) 1.13

Pulmonary haemorrhage and haemolytic anaemia due to trimellitic anhydride. Lancet (1979) 1.12

The spectrum of radiologic findings in allergic bronchopulmonary aspergillosis. Radiology (1978) 1.12

Formation of drusen in the human eye. Am J Ophthalmol (1986) 1.11

Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy (1986) 1.11

Beclomethasone diproprionate for severe asthma during pregnancy. Ann Intern Med (1983) 1.11

Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol (1984) 1.11

Gastric bacteria other than Helicobacter pylori. Gastroenterol Clin North Am (1993) 1.10

Histamine release from leukocytes of hypersensitive individuals. I. Use of several antigens. J Allergy (1966) 1.10

Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol (1981) 1.10

Two pretreatment regimens for high-risk patients receiving radiographic contrast media. J Allergy Clin Immunol (1984) 1.10

Activity of Thylakoid-bound Ribosomes in Pea Chloroplasts. Plant Physiol (1978) 1.09

The use of IgE mediated responses as a pharmacologic test system. The effect of disodium cromoglycate in respiratory and cutaneous reactions and on the electrocardiograms of rhesus monkeys. Int Arch Allergy Appl Immunol (1971) 1.09

Potentially fatal asthma and syncope. A new variant of Munchausen's syndrome in sports medicine. Chest (1991) 1.09

Reverse passive respiratory reactions due to anti-IgE in rhesus monkeys. Clin Exp Immunol (1972) 1.09

The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. J Lab Clin Med (1983) 1.09

In vitro production of IgE by human peripheral blood lymphocytes: effect of cholera toxin and beta adrenergic stimulation. J Immunol (1976) 1.09

The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med (1976) 1.08

Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study. J Nutr (2000) 1.07

On sudden death. Circulation (1971) 1.07

Demonstration of high-energy 2 omega (526.5 nm) operation on the National Ignition Facility Laser System. Appl Opt (2008) 1.07